Previous close | 322.60 |
Open | 330.30 |
Bid | 330.20 x 0 |
Ask | 330.50 x 0 |
Day's range | 330.30 - 330.30 |
52-week range | 240.10 - 330.30 |
Volume | |
Avg. volume | 1 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 29 Apr 2024 - 03 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Lantheus' (LNTH) focus on pipeline development raises optimism about the stock.
Boston Scientific (BSX) and Scivita Medical announce an expanded strategic cooperation arrangement.
Abbott's (ABT) Assert-IQ ICM enables regular monitoring for abnormal heart rhythms, as well as technologies to improve data management and workflow.